1,415
Views
27
CrossRef citations to date
0
Altmetric
Brief Report

Impact of daptomycin resistance on Staphylococcus aureus virulence

, , , , , & show all
Pages 127-131 | Received 28 Nov 2014, Accepted 21 Jan 2015, Published online: 08 Apr 2015

References

  • Fowler VG, Jr., Boucher HW, Corey GR, Abrutyn E, Karchmer AW, Rupp ME, Levine DP, Chambers HF, Tally FP, Vigliani GA, et al. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med 2006; 355:653-65; PMID:16914701; http://dx.doi.org/10.1056/NEJMoa053783
  • Hayden MK, Rezai K, Hayes RA, Lolans K, Quinn JP, Weinstein RA. Development of Daptomycin resistance in vivo in methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2005; 43:5285-7; PMID:16207998; http://dx.doi.org/10.1128/JCM.43.10.5285-5287.2005
  • Marty FM, Yeh WW, Wennersten CB, Venkataraman L, Albano E, Alyea EP, Gold HS, Baden LR, Pillai SK. Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis. J Clin Microbiol 2006; 44:595-7; PMID:16455920; http://dx.doi.org/10.1128/JCM.44.2.595-597.2006
  • Ernst CM, Staubitz P, Mishra NN, Yang SJ, Hornig G, Kalbacher H, Bayer AS, Kraus D, Peschel A. The bacterial defensin resistance protein MprF consists of separable domains for lipid lysinylation and antimicrobial peptide repulsion. PLoS Pathog 2009; 5:e1000660; PMID:19915718; http://dx.doi.org/10.1371/journal.ppat.1000660
  • Peleg AY, Miyakis S, Ward DV, Earl AM, Rubio A, Cameron DR, Pillai S, Moellering RC, Jr., Eliopoulos GM. Whole genome characterization of the mechanisms of daptomycin resistance in clinical and laboratory derived isolates of Staphylococcus aureus. PLoS One 2012; 7:e28316; PMID:22238576; http://dx.doi.org/10.1371/journal.pone.0028316
  • Dubrac S, Msadek T. Identification of genes controlled by the essential YycG/YycF two-component system of Staphylococcus aureus. J Bacteriol 2004; 186:1175-81; PMID:14762013; http://dx.doi.org/10.1128/JB.186.4.1175-1181.2004
  • Howden BP, McEvoy CR, Allen DL, Chua K, Gao W, Harrison PF, Bell J, Coombs G, Bennett-Wood V, Porter JL, et al. Evolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulator WalKR. PLoS Pathog 2011; 7:e1002359
  • Friedman L, Alder JD, Silverman JA. Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus. Antimicrob Agents Chemother 2006; 50:2137-45; PMID:16723576; http://dx.doi.org/10.1128/AAC.00039-06
  • Rubio A, Moore J, Varoglu M, Conrad M, Chu M, Shaw W, Silverman JA. LC-MS/MS characterization of phospholipid content in daptomycin-susceptible and -resistant isolates of Staphylococcus aureus with mutations in mprF. Mol Membr Biol 2012; 29:1-8; PMID:22276671; http://dx.doi.org/10.3109/09687688.2011.640948
  • Peleg AY, Monga D, Pillai S, Mylonakis E, Moellering RC, Jr., Eliopoulos GM. Reduced susceptibility to vancomycin influences pathogenicity in Staphylococcus aureus infection. J Infect Dis 2009; 199:532-6; PMID:19125671; http://dx.doi.org/10.1086/596511
  • Gao W, Chua K, Davies JK, Newton HJ, Seemann T, Harrison PF, Holmes NE, Rhee HW, Hong JI, Hartland EL, et al. Two novel point mutations in clinical Staphylococcus aureus reduce linezolid susceptibility and switch on the stringent response to promote persistent infection. PLoS Pathog 2010; 6:e1000944; PMID:20548948; http://dx.doi.org/10.1371/journal.ppat.1000944
  • Silverman JA, Oliver N, Andrew T, Li T. Resistance studies with daptomycin. Antimicrob Agents Chemother 2001; 45:1799-802; PMID:11353628; http://dx.doi.org/10.1128/AAC.45.6.1799-1802.2001
  • Yang SJ, Nast CC, Mishra NN, Yeaman MR, Fey PD, Bayer AS. Cell wall thickening is not a universal accompaniment of the daptomycin nonsusceptibility phenotype in Staphylococcus aureus: evidence for multiple resistance mechanisms. Antimicrob Agents Chemother 2010; 54:3079-85; PMID:20498310; http://dx.doi.org/10.1128/AAC.00122-10
  • Peschel A, Jack RW, Otto M, Collins LV, Staubitz P, Nicholson G, Kalbacher H, Nieuwenhuizen WF, Jung G, Tarkowski A, et al. Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine. J Exp Med 2001; 193:1067-76; PMID:11342591; http://dx.doi.org/10.1084/jem.193.9.1067
  • Weidenmaier C, Kristian SA, Peschel A. Bacterial resistance to antimicrobial host defenses–an emerging target for novel antiinfective strategies? Current drug targets 2003; 4:643-9; PMID:14577655; http://dx.doi.org/10.2174/1389450033490731
  • Hayden MK, Rezai K, Hayes RA, Lolans K, Quinn JP, Weinstein RA. Development of Daptomycin resistance in vivo in methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2005; 43:5285-7; PMID:16207998; http://dx.doi.org/10.1128/JCM.43.10.5285-5287.2005
  • Marty FM, Yeh WW, Wennersten CB, Venkataraman L, Albano E, Alyea EP, Gold HS, Baden LR, Pillai SK. Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis. J Clin Microbiol 2006; 44:595-7; PMID:16455920; http://dx.doi.org/10.1128/JCM.44.2.595-597.2006
  • Gasch O, Camoez M, Dominguez MA, Padilla B, Pintado V, Almirante B, Martin C, Lopez-Medrano F, de Gopegui ER, Blanco JR, et al. Emergence of resistance to daptomycin in a cohort of patients with methicillin-resistant Staphylococcus aureus persistent bacteraemia treated with daptomycin. J Antimicrob Chemother 2014; 69:568-71; PMID:24107389; http://dx.doi.org/10.1093/jac/dkt396

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.